ヒトで検討された
ヒトを対象とした発表済みの研究があります。ただし、米国や欧州連合で認可された医薬品ではありません。
このページは作成途中です
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
作用の強さ
どこまで到達したか
どの医薬品も同じ段階を上っていきます。ほとんどの化合物は頂点に届かず、どの段階にあるかによって、その主張がどこまで支えられるかが分かります。
- 承認された医薬品
規制当局が試験を審査し、特定の用途に対して承認したものです。
- 第3相
数千人を含むこともある大規模なランダム化試験で、プラセボまたは標準治療と比較します。
- 第2相
病態のある人を対象に、用量と効果の関係を測定する中規模の試験です。
- 第1相および初期のヒト試験: Hexarelin
人を対象とした最初の試験で、安全性と体内での扱われ方を調べます。
- 細胞および動物
実験室および動物での研究です。動物での結果は人での結果ではありません。
- 291
- PubMed上の論文
- 169
- うち人を対象としたもの
- 26
- ランダム化試験
- 23
- 総説
件数は、どれだけ公表されたかを示すもので、何が分かったかを示すものではありません。PubMed上の件数: 2026-11-16
取り扱いと溶解
粉末から測定された試料まで
The same four steps for any lyophilized vial. Laboratory handling, not use in a person.
1. バイアルのラベルを読む
ラベルには、バイアル内のペプチドの質量がミリグラム単位で記載されています。この数値が、すべての計算の出発点です。
2. 希釈液を加える
計量した量の希釈液を、ガラス壁を伝わせてゆっくり加えます。やさしく回し混ぜてください。振るとペプチドを損なうおそれがあります。
3. 濃度を求める
Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.
4. 試料の量を測る
必要な体積は、必要な質量を濃度で割ったものです。U-100注射器では、1 mLが100単位です。
以下の計算機で計算を行い、その過程を表示します。
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on Hexarelin itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Hexarelin; no amount here is a recommendation.
Hexarelin: PubMedで
What PubMed held for Hexarelin on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 291
- papers
- 169
- in humans
- 58
- clinical trials
- 26
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- Does desensitization to hexarelin occur?
TrialRahim A, Shalet SM Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 1998. PMID 10990150
- Hexarelin induced growth hormone release is influenced by exogenous growth hormone
Randomized trialMassoud AF, Hindmarsh PC, Brook CG Clinical endocrinology, 1995. PMID 8548947
- The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency
TrialLoche S, Cambiaso P, Merola B, et al. The Journal of clinical endocrinology and metabolism, 1995. PMID 7673411
- Lack of effect of hexarelin on TRH-induced TSH response in normal adult man
TrialArosio M, Casati G, Biella O, et al. Journal of endocrinological investigation, 1998. PMID 9624598
- The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin
Randomized trialKorbonits M, Kaltsas G, Perry LA, et al. The Journal of clinical endocrinology and metabolism, 1999. PMID 10404825
- Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients
Randomized trialCiccarelli E, Grottoli S, Razzore P, et al. Clinical endocrinology, 1996. PMID 8706295
- The cardiovascular action of hexarelin
ReviewMao Y, Tokudome T, Kishimoto I Journal of geriatric cardiology : JGC, 2014. PMID 25278975
- Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway
StudyGuan C, Li C, Shen X, et al. European journal of medical research, 2023. PMID 37710348
Search used: ("Hexarelin"[tiab]). Run it on PubMed
研究リンク
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for Hexarelin on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.